Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

APOBEC3B Potently Restricts HIV-2 but Not HIV-1 in a Vif-Dependent Manner

Journal of Virology(2021)10.1128/jvi.01170-21Source: DataRank Database

APOBEC3B Potently Restricts HIV-2 but Not HIV-1 in a Vif-Dependent Manner is a research paper published in Journal of Virology (2021). On theSindex it has a DataRank of 0. It has been cited 11 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access11 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 0.82)OA: greenTopics (49)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Eri Miyagi ORCID,Ana Clara Ribeiro,João Gonçalves ORCID,Klaus Strebel ORCID,Isabel Barahona ORCID

Live enrichment

PubMed:34523960 PMC:PMC8577350 OpenAlex:https://openalex.org/W3199927528

Division of Intramural Research, National Institute of Allergy and Infectious Diseases

Grant: 1 Z01 AI000669

MEC | Fundação para a Ciência e a Tecnologia

Grant: SFRH/BD/81921/2011

SEARCHING APOBEC PROTEIN RESPONSIBLE FOR INHIBITION OF HIV-2 VIF DEFICIENT VIRUS

MEC | Fundação para a Ciência e a Tecnologia

Grant: PTDC/BIM-MEC/6631/2014

Breast cancer therapeutics with Vif

Intramural NIH HHS

Grant: Z01 AI000669

FWCI

0.82

Citation Percentile

0.7%

Citation Trend

2023

2024

2025

2026

greenLicense: https://doi.org/10.1128/ASMCopyrightv2

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8577350

publisherhttps://journals.asm.org/doi/pdf/10.1128/JVI.01170-21

journalhttps://doi.org/10.1128/jvi.01170-21

repositoryhttps://pubmed.ncbi.nlm.nih.gov/34523960

Fields of Study

HIV Research and TreatmentVirus-based gene therapy researchHIV/AIDS drug development and treatment0301 basic medicine03 medical and health sciencesAnimalsCytidine DeaminaseGene Products, vifHEK293 CellsHIV InfectionsHIV-1HIV-2HumansMinor Histocompatibility AntigensReceptor, EphB2vif Gene Products, Human Immunodeficiency Virus

MeSH Terms

AnimalsCytidine DeaminaseHumansHIV-1HIV-2HIV InfectionsMinor Histocompatibility AntigensGene Products, vifReceptor, EphB2vif Gene Products, Human Immunodeficiency VirusHEK293 Cells

Keywords

Cytidine deaminaseGeneHEK 293 cellsMutationCytidineAdaptation (eye)Viral replicationENCODEViral proteinVirusHIV-1HIV-2Apobec3VifGene Products, vifReceptor, EphB2HIV InfectionsMinor Histocompatibility AntigensHEK293 Cellsvif Gene Products, Human Immunodeficiency VirusAnimalsHumans

Sustainable Development Goals

SDG 3: 3. Good health